Omnia Education

Viewing Contraceptive Efficacy/Effectiveness Through a New Lens

Viewing Contraceptive Efficacy/Effectiveness Through a New Lens
RestartResume

Recent clinical trials of contraceptives have demonstrated a “Creeping Pearl Index”, this article describes factors that contribute.

Available credits: 0.25

Time to complete: 15 minutes

Released:

Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    A number of new contraceptive methods have been approved over the past several years, including a patch, a vaginal ring, and a vaginal pH modulator gel. It is important that clinicians have information surrounding these methods that will help them appropriately counsel their patients who are seeking contraception. An important factor in the patient decision-making process is the contraceptive effectiveness of the method.  This article will not only discuss these various methods, but also how contemporary clinical trials of contraceptives have demonstrated a “Creeping Pearl Index” and the importance of clinicians understanding the factors that contribute to this.

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. GLC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Faculty:

    David J. Portman, MD
    Director Emeritus, Columbus Center for Women’s Health Research
    Adjunct Instructor, Obstetrics and Gynecology
    The Ohio State University College of Medicine
    Columbus, OH 

    Advisory Board: Evofem
    Consulting Fees: Agile Therapeutics, Sebela
    Research Grants: Agile Therapeutics
    Shareholder: Sermonix Pharmaceuticals

    Reviewers/Content Planners/Authors:

    • Sean T. Barrett has nothing to disclose.
    • Barry A. Fiedel, PhD has nothing to disclose.
    • Amanda Hilferty has nothing to disclose.
    • Robert S. Schneider, MSW has nothing to disclose.
  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Review current contraception options, unmet needs, and recent approvals.
    • Identify information that will overcome the most common misperceptions that clinicians may hold regarding contraceptive patches and other non-long acting reversible contraception (LARC) methods.
    • Explain the advantages and drawbacks of contraceptive patches and non-LARC methods.
    • Discuss the scientific data underlying “typical” and “perfect” use and the “Creeping Pearl Index” demonstrated in contemporary clinical trials of contraception.
  • Target Audience

    This activity is designed to meet the educational needs of obstetricians/gynecologists, nurse practitioners, physician assistants, nurses, certified nurse midwives, and primary care physicians with a focus on women’s health.

  • Accreditation and Credit Designation Statements

    Global Learning Collaborative is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Global Learning Collaborative designates this enduring material for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider(s)/Educational Partner(s)

    Omnia Education is the leading provider of education for women’s health professionals. Our activities are recognized nationwide for providing credible, relevant, and practical information on issues impacting the female patient. Additionally, our unique focus has transformed the CME learning environment, and our ability to help learners recognize and overcome barriers to optimal performance and optimal patient outcomes has positioned us as a leader in women’s health education.

  • Commercial Support

    This activity is supported by an independent educational grant from Agile Pharmaceuticals.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Omnia Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Omnia Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited

    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience.

Facebook Comments

Register

We’re glad to see you’re enjoying Omnia Education…
but how about a more personalized experience?

Register for free